Clinical trial NCT03955757: Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination
Official title: Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Primary Prevention
Keywords: Immunization
Boot Camp Translation
Adolescent
Lead sponsor: University of Colorado, Denver
Sponsor class: OTHER
Collaborators: name: Centers for Disease Control and Prevention
First posted: 2019-05-20
Enrollment: 6000
Sex: ALL
Minimum age (years): 11
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.

Detailed description: Boot Camp Translation (BCT) is a process to identify strategies that help communities improve health. It is a 6-month, facilitated, iterative community engagement process that brings together relevant stakeholders to develop and implement locally meaningful messages, materials, and strategies for health topics of interest.

This is a novel community engagement process that has a proven ability to result in meaningful and impactful strategies to improve compliance with recommended health behaviors in rural communities. The investigators will expand this work by testing BCT on its ability to improve vaccination with all recommend adolescent vaccines (Tdap, MenACWY, HPV, Flu).

The investigators will conduct a randomized, controlled trial in which 4 rural communities in Western Colorado will undergo BCT to develop and implement strategies to increase adolescent vaccination. Vaccination rates will be compared to 4 control communities that do not undergo BCT.

Eligibility criteria: Inclusion Criteria:

* Must live in one of the designated Colorado communities

Exclusion Criteria:

* Does not live in one of the designated Colorado communities

Primary outcomes:
measure: Initiation of HPV vaccination series, 11-12 year olds
timeFrame: Up to 24 months
Secondary outcomes:
measure: Completion of HPV vaccination series, 11-12 year olds
timeFrame: Up to 24 months
measure: Initiation of HPV vaccination series, 13-17 year olds
timeFrame: Up to 24 months
measure: Completion of HPV vaccination series, 13-17 year olds
timeFrame: Up to 24 months
measure: Receipt of Tdap vaccine, 11-12 year olds
timeFrame: Up to 24 months
measure: Receipt of Tdap vaccine, 13-17 year olds
timeFrame: Up to 24 months
measure: Receipt of MCV vaccine, 11-12 year olds
timeFrame: Up to 24 months
measure: Receipt of MCV vaccine, 13-17 year olds
timeFrame: Up to 24 months
Other outcomes:
measure: Receipt of influenza vaccine
timeFrame: Up to 24 months
Locations:
city: Aurora
country: United States
facility: University of Colorado Anschutz Medical Campus
state: Colorado
Study officials:
affiliation: University of Colorado, Denver
name: Sean T O'Leary, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Colorado, Denver
name: Amanda Dempsey, MD, PhD, MPH
role: PRINCIPAL_INVESTIGATOR
References: